Coya Therapeutics (COYA) Net Shares Issued and Repurchased (2022 - 2026)

Coya Therapeutics has disclosed Net Shares Issued and Repurchased across 5 years of filings, most recently posting $887428.0 for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased rose 4.5% year-over-year to $887428.0; the TTM figure through Mar 2026 stood at $887428.0 (up 4.5% YoY), while the FY2025 annual figure was $924196.0, down 16.08% from the prior year.
• Net Shares Issued and Repurchased came in at $887428.0 for Q1 2026 at Coya Therapeutics, down from $924196.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.1 million in Q4 2024 to a low of $151433.0 in Q4 2022.
• Average Net Shares Issued and Repurchased over 5 years is $722003.0, with a median of $804619.0 recorded in 2023.
• Year-over-year, Net Shares Issued and Repurchased jumped 401.9% in 2023 and fell 16.08% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $151433.0 in 2022, then jumped by 401.9% to $760042.0 in 2023, then surged by 44.91% to $1.1 million in 2024, then slipped by 16.08% to $924196.0 in 2025, then dropped by 3.98% to $887428.0 in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $887428.0 in Q1 2026, $924196.0 in Q4 2025, and $849196.0 in Q1 2025.